Matinas BioPharma Holdings Inc At The Biotech Showcase Transcript
All right. We're going to start our next presentation by Matinas BioPharma from Bedminster, New Jersey, Matinas BioPharma is focused on hematology, infectious disease, and inflammation. Presenting for Matinas BioPharma is their CEO, Jerome Jabbour. Please go ahead.
Thank you very much. It's great to be back at Biotech Showcase. It's always a great opportunity to kick off the year. And it's especially important for us because the fourth quarter for us, there was a lot of news. So it gives us an opportunity to sort of recap some of the data announcements we made, put them in context and then create expectations and milestones for what we hope to achieve in 2024.
I will be making forward-looking statements, so please, we would encourage you to check our SEC filings and be aware of all of the risks. Matinas is all about drug delivery. This is a platform drug delivery play with the technology that lends itself to intracellular delivery. But it takes things to the next level because it
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |